Toggle menu

EMERGE Biobank

Start date:
June 2013
End date:
December 2015
Co-ordinated by:
EMERGE

The Emergency Medicine Annotated Bioresource Consortium (EM-ABC): A pilot and feasability programme

 

 Aim

To develop the infrastructure and pilot a prospective, consecutive, emergency, bioresource that will subsequently be developed for all emergency presentations

Trial Design

A pilot and feasibility programme to establish a bioresource to provide consecutive emergency samples, thus enabling investigation of the development of the acute disease/influence of disease modifiers e.g. treatment and resuscitation.

Chief Investigator

Dr Matt Reed

Local PI

Dr Matt Reed

Research Team

Paul Leonard, Sandra McGillivray, TRAK development team

Dawn Lyster, John Connolly, RIE laboratories

 

Chief Investigator

Dr Matt Reed

Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine

Local PI

Dr Matt Reed

Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine

Research Team

Rachel O'Brien

Lead Research Nurse

More EMERGE Trials

Assessing the impact of the Minimum Unit Pricing

Read more

Minimal Unit Pricing Study (MUP)

Assessing the impact of the Minimum Unit Pricing

Intervention
1. Ambulatory Device, Rocket Pleural vent insertion
2. Standard Treatment, Aspiration +/- chest drain
Primary Outcome Measures
To assess whether use of an ambulatory device (Rocket Pleural Vent) and treatment strategy reduces hospital stay. Total length of stay in hospital up to 30 days post randomisation. Up to 30 days post randomisation.

Read more

RAMPP trial

RAMPP trial - Randomised Controlled Trial: Pleural vent (rocket) V standard care in Primary Spontaneous Pnuemothorax

Molecular and cellular analysis of intracranial tumours

Read more

BRAINED

Molecular and cellular analysis of intracranial tumours